Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 568

1.

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, Clark RE, Cortes JE, Deininger MW, Guilhot F, Hjorth-Hansen H, Hughes TP, Janssen JJWM, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Mayer J, Nicolini F, Niederwieser D, Pane F, Radich JP, Rea D, Richter J, Rosti G, Rousselot P, Saglio G, Saußele S, Soverini S, Steegmann JL, Turkina A, Zaritskey A, Hehlmann R.

Leukemia. 2020 Mar 3. doi: 10.1038/s41375-020-0776-2. [Epub ahead of print] Review.

PMID:
32127639
2.

Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia.

Giona F, Malaspina F, Putti MC, Ladogana S, Mura R, Burnelli R, Vacca N, Rizzo L, Bianchi S, Moleti ML, Testi AM, Biondi A, Locatelli F, Saglio G, Foà R.

Br J Haematol. 2020 Mar;188(6):e101-e105. doi: 10.1111/bjh.16388. Epub 2020 Feb 22. No abstract available.

PMID:
32087030
3.

Prospects for achieving treatment-free remission in chronic myeloid leukaemia.

Saglio G, Gale RP.

Br J Haematol. 2020 Feb 14. doi: 10.1111/bjh.16506. [Epub ahead of print] Review.

PMID:
32057102
4.

Nanocarriers as Magic Bullets in the Treatment of Leukemia.

Houshmand M, Garello F, Circosta P, Stefania R, Aime S, Saglio G, Giachino C.

Nanomaterials (Basel). 2020 Feb 6;10(2). pii: E276. doi: 10.3390/nano10020276. Review.

5.

Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes.

Rosso V, Petiti J, Dragani M, Andreani G, Croce E, Lo Iacono M, Saglio G, Fava C, Cilloni D.

Ann Hematol. 2020 Apr;99(4):891-893. doi: 10.1007/s00277-020-03913-x. Epub 2020 Feb 4. No abstract available.

PMID:
32016578
6.

Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia.

Petiti J, Rosso V, Croce E, Franceschi V, Andreani G, Dragani M, De Gobbi M, Lunghi M, Saglio G, Fava C, Lo Iacono M, Cilloni D.

J Clin Med. 2020 Jan 19;9(1). pii: E271. doi: 10.3390/jcm9010271.

7.

Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?

Mughal TI, Deininger MW, Kucine N, Saglio G, Van Etten RA.

Hemasphere. 2019 Aug 1;3(5):e283. doi: 10.1097/HS9.0000000000000283. eCollection 2019 Oct. No abstract available.

8.

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.

Soverini S, Bavaro L, De Benedittis C, Martelli M, Iurlo A, Orofino N, Sica S, Sorà F, Lunghi F, Ciceri F, Galimberti S, Baratè C, Bonifacio M, Scaffidi L, Castagnetti F, Gugliotta G, Albano F, Russo Rossi AV, Stagno F, di Raimondo F, D'Adda M, di Bona E, Abruzzese E, Binotto G, Sancetta R, Salvucci M, Capodanno I, Girasoli M, Coluzzi S, Attolico I, Musolino C, Calistri E, Annunziata M, Bocchia M, Stella S, Serra A, Errichiello S, Saglio G, Pane F, Vigneri P, Mignone F, Laginestra MA, Pileri SA, Percesepe A, Tenti E, Rosti G, Baccarani M, Cavo M, Martinelli G.

Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.

PMID:
31877211
9.

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.

Baccarani M, Abruzzese E, Accurso V, Albano F, Annunziata M, Barulli S, Beltrami G, Bergamaschi M, Binotto G, Bocchia M, Caocci G, Capodanno I, Cavazzini F, Cedrone M, Cerrano M, Crugnola M, D'Adda M, Elena C, Fava C, Fazi P, Fozza C, Galimberti S, Giai V, Gozzini A, Gugliotta G, Iurlo A, La Barba G, Levato L, Lucchesi A, Luciano L, Lunghi F, Lunghi M, Malagola M, Marasca R, Martino B, Melpignano A, Miggiano MC, Montefusco E, Musolino C, Palmieri F, Pregno P, Rapezzi D, Rege-Cambrin G, Rupoli S, Salvucci M, Sancetta R, Sica S, Spadano R, Stagno F, Tiribelli M, Tomassetti S, Trabacchi E, Bonifacio M, Breccia M, Castagnetti F, Pane F, Russo D, Saglio G, Soverini S, Vigneri P, Rosti G.

Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

10.

Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia.

Carrà G, Nicoli P, Lingua MF, Maffeo B, Cartellà A, Circosta P, Brancaccio M, Parvis G, Gaidano V, Guerrasio A, Saglio G, Taulli R, Morotti A.

J Cell Mol Med. 2020 Jan;24(2):1650-1657. doi: 10.1111/jcmm.14857. Epub 2019 Dec 10.

11.

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper.

Soverini S, Abruzzese E, Bocchia M, Bonifacio M, Galimberti S, Gozzini A, Iurlo A, Luciano L, Pregno P, Rosti G, Saglio G, Stagno F, Tiribelli M, Vigneri P, Barosi G, Breccia M.

J Hematol Oncol. 2019 Dec 5;12(1):131. doi: 10.1186/s13045-019-0815-5. Review.

12.

Bone marrow microenvironment: The guardian of leukemia stem cells.

Houshmand M, Blanco TM, Circosta P, Yazdi N, Kazemi A, Saglio G, Zarif MN.

World J Stem Cells. 2019 Aug 26;11(8):476-490. doi: 10.4252/wjsc.v11.i8.476. Review.

13.

Synergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literature.

Cilloni D, Andreani G, Dragani M, De Gobbi M, Saglio G.

Leuk Lymphoma. 2020 Jan;61(1):234-236. doi: 10.1080/10428194.2019.1660969. Epub 2019 Sep 10. No abstract available.

PMID:
31502895
14.

Reduced Expression of Sprouty1 Contributes to the Aberrant Proliferation and Impaired Apoptosis of Acute Myeloid Leukemia Cells.

Rosso V, Panuzzo C, Petiti J, Carturan S, Dragani M, Andreani G, Fava C, Saglio G, Bracco E, Cilloni D.

J Clin Med. 2019 Jul 4;8(7). pii: E972. doi: 10.3390/jcm8070972.

15.

Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia.

Dragani M, Rege-Cambrin G, Ferrero D, Abruzzese E, Pregno P, Elena C, Cedrone M, Santoro M, Andreani G, Saglio G, Fava C.

Leuk Lymphoma. 2019 Dec;60(13):3330-3332. doi: 10.1080/10428194.2019.1622103. Epub 2019 Jun 4. No abstract available.

PMID:
31161827
16.

Chronic myeloid leukemia stem cells.

Houshmand M, Simonetti G, Circosta P, Gaidano V, Cignetti A, Martinelli G, Saglio G, Gale RP.

Leukemia. 2019 Jul;33(7):1543-1556. doi: 10.1038/s41375-019-0490-0. Epub 2019 May 24. Review.

17.

Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?

Cilloni D, Petiti J, Rosso V, Andreani G, Dragani M, Fava C, Saglio G.

Int J Mol Sci. 2019 May 7;20(9). pii: E2249. doi: 10.3390/ijms20092249. Review.

18.

Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?

Saglio G, Fava C, Gale RP.

Haematologica. 2019 May;104(5):862-864. doi: 10.3324/haematol.2018.214445. No abstract available.

19.

Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms.

Mughal TI, Pemmaraju N, Radich JP, Deininger MW, Kucine N, Kiladjian JJ, Bose P, Gotlib J, Valent P, Chen CC, Barbui T, Rampal R, Verstovsek S, Koschmieder S, Saglio G, Van Etten RA.

Hematol Oncol. 2019 Aug;37(3):240-252. doi: 10.1002/hon.2622. Epub 2019 Jun 20. Review.

PMID:
31013548
20.

Chronic Myeloproliferative Neoplasms: Some Remaining Challenges.

Mughal TI, Saglio G, Van Etten RA.

Hemasphere. 2018 Oct;2(5):e147. doi: 10.1097/HS9.0000000000000147. Epub 2018 Oct 2. No abstract available.

Supplemental Content

Loading ...
Support Center